Clinical trials
Female Fertility clinical trials
Below are recruiting female fertility clinical trials, each written for real people, not researchers. We’re tracking 18 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07231510Recruiting
Chlordecone exposure and female fertility study
This study looks at how exposure to chlordecone, a chemical found in some Caribbean soils, might affect a woman's ability to get pregnant. You may be asked to share your medical history and provide samples to help us understand this link.
Pointe-à-PitreAges 18–39 - NCT06360471Recruiting
Preserving fertility in women with cancer
This study helps women with cancer keep their ability to have children after treatment. It offers egg or embryo freezing and checks on pregnancy and baby health later on.
Nanjing, JiangsuAges 20–40 - NCT04866329Recruiting
Study of stress and environmental exposures in IVF fertility
This study looks at how environmental exposures and stress-related “oxidant” changes may affect fertility outcomes in IVF for women. You may be invited if you are in your first IVF egg retrieval cycle and meet the study’s specific IVF setup rules.
ToursAges 18–43 - NCT07312058Recruiting
Fertility preservation after cancer: a long-term study
This study follows women who have had cancer or a blood disorder and chose to preserve their fertility before treatment. Researchers want to see how well these preservation methods work over time.
AmiensAges 18–47 - NCT07471373Recruiting
Pesticides and infertility study in endometriosis
This study looks at how pesticides might affect fertility in women with endometriosis, focusing on stress markers and gut/genital bacteria. You will provide samples and answer questions so researchers can compare women with and without endometriosis.
SalouëlAges 18–43 - NCT06626282Recruiting
Fertility after childhood cancer in women
This study looks at how well the ovaries work in women who had childhood cancer. Researchers want to know if cancer treatments affected fertility.
Liège, WalloniaAges 18–50 - NCT07175571Recruiting
Comparing insemination methods with frozen donor sperm in IVF
This study compares different insemination methods when using frozen donor sperm during IVF. It aims to find the best technique to help more eggs get fertilized.
Rockville, MarylandAges Any age - NCT05328258RecruitingPhase 3
Triptorelin to help protect fertility during cancer chemotherapy
This Phase 3 study tests whether a hormone medicine called triptorelin (a GnRH “fertility-protecting” medicine) can better protect ovarian function while you receive chemotherapy. The goal is to help preserve fertility and reduce the risk of early ovarian failure from cancer treatment.
GothenburgAges 14–42 - NCT07108621RecruitingPhase 3
HCG priming before IVF for low egg reserve
This trial tests whether giving a hormone called hCG before starting IVF can improve outcomes for women with low egg reserve (low AMH). It is designed for women under 40 who are early in their IVF journey.
CopenhagenAges 18–40 - NCT06122207Recruiting
Probiotic for women with fertility issues and IVF
This study tests whether a probiotic (a pill with beneficial bacteria) can help improve the health of the female genital tract for people with fertility problems who are undergoing IVF. It aims to see if this can improve chances of pregnancy.
LisbonAges 18–45 - NCT06921395RecruitingPhase 4
Comparing two fertility drugs for IVF in women under 40
This trial tests how well and safely a new drug (Fang Le Shu) works compared to a standard drug (Guo Na Fen) for stimulating the ovaries to produce eggs for IVF. It may help women who have had trouble getting pregnant for at least a year.
ZhengzhouAges 20–39 - NCT07500337Recruiting
Improving embryos with fragmentation for IVF success
This trial tests a special technique to remove fragments from day-4 embryos before they grow into blastocysts. It may help people having IVF get better embryos and improve pregnancy chances.
Bisceglie, BTAges 20–42 - NCT05473273Recruiting
Blood test study during normal frozen embryo transfer
This study measures changes in your blood immune markers during frozen embryo transfer when the embryo is chromosomally normal. It may help clinics understand what blood immune patterns relate to successful pregnancy in natural or hormone-prepared cycles.
Abu Dhabi, Abu Dhabi EmirateAges 18–40 - NCT05969574Recruiting
Study links miscarriage history to low egg supply
This study looks at whether having multiple early miscarriages is connected to having a lower egg supply. It compares miscarriage history with “ovarian reserve” in people seen at specific fertility clinics.
Abu Dhabi, Abu Dhabi EmirateAges Any age - NCT06459778Recruiting
A new lab method to help eggs develop in IVF for women 35–42
This study is testing a special lab technique called Piezo-ICSI to see if it can improve the chances of a fertilized egg developing normally in women ages 35–42 who are going through IVF or ICSI. It may help if you've had fewer than 3 previous cycles and don’t have certain uterine or genetic issues.
Nanjing, JiangsuAges 35–42 - NCT04390308Recruiting
Testing gentle stimulation of ovaries before fertility treatment
This trial studies whether a “mechanical stimulation” procedure can help small egg-making structures in the ovary start to work again in people with primary ovarian insufficiency. If the procedure shows signs of response, you may then move on to further fertility treatment, including IVF.
Abu Dhabi, Abu Dhabi EmirateAges 18–40 - NCT05837325Recruiting
Testing whether AMH levels predict embryo chromosome status
This study looks at whether a hormone level measured inside the fluid around eggs (follicular fluid) can predict whether embryos have the correct number of chromosomes. It may help clinics choose which embryos are more likely to be healthy.
Abu Dhabi, Abu Dhabi EmirateAges 18–40 - NCT05969795RecruitingPhase 1
Natural embryo transfer with or without progesterone support
This Phase 1 study compares pregnancy outcomes, especially live birth, when using a natural-cycle frozen embryo transfer with an embryo that is genetically euploid (normal chromosome number) versus doing transfers without luteal (progesterone) phase support. It may help determine whether adding progesterone around ovulation improves the chance of a live birth.
Abu DhabiAges 18–40
Hear when a new Female Fertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for female fertility?
- Yes. Clin2 currently lists 18 recruiting female fertility studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a female fertility trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a female fertility trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.